Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01689974
What this trial is testing

Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
NYU Langone Health 10
Not applicableStudy completedNCT01886235
What this trial is testing

Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)UnknownNCT00991250
What this trial is testing

SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
SentoClone AB 140
Testing effectiveness (Phase 2)Ended earlyNCT01801358
What this trial is testing

A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Array Biopharma, now a wholly owned subsidiary of Pfizer 38
Testing effectiveness (Phase 2)UnknownNCT01092585
What this trial is testing

Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH

Who this might be right for
Melanoma
Genta Incorporated 27
Testing effectiveness (Phase 2)Study completedNCT00911443
What this trial is testing

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
sigma-tau i.f.r. S.p.A. 488
Testing effectiveness (Phase 2)Study completedNCT01928940
What this trial is testing

Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part)

Who this might be right for
Solid Tumours
GlaxoSmithKline 12
Early research (Phase 1)Ended earlyNCT02200562
What this trial is testing

Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma

Who this might be right for
Stage III or IV Melanoma
University of Utah 6
Testing effectiveness (Phase 2)Study completedNCT00104897
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Cancer Research UK 25
Testing effectiveness (Phase 2)Study completedNCT01134250
What this trial is testing

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

Who this might be right for
Solid TumorBreast CancerMetastatic Melanoma+1 more
Philogen S.p.A. 48
Testing effectiveness (Phase 2)UnknownNCT01331915
What this trial is testing

Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients

Who this might be right for
Melanoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 23
Testing effectiveness (Phase 2)Ended earlyNCT02562625
What this trial is testing

Trial of Pembrolizumab and Radiotherapy in Melanoma

Who this might be right for
Melanoma
Royal Marsden NHS Foundation Trust 17
Testing effectiveness (Phase 2)Study completedNCT00463892
What this trial is testing

High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes

Who this might be right for
Melanoma
Redwood Regional Medical Group 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06157099
What this trial is testing

Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma

Who this might be right for
Pathologic Stage IIIA Cutaneous Melanoma AJCC v8Pathologic Stage IIA Cutaneous Melanoma AJCC v8Pathologic Stage IIB Cutaneous Melanoma AJCC v8
OHSU Knight Cancer Institute 150
Testing effectiveness (Phase 2)Study completedNCT00261404
What this trial is testing

TNFerade™ Biologic Plus Radiation for Metastatic Melanoma

Who this might be right for
Melanoma
GenVec
Testing effectiveness (Phase 2)Active Not RecruitingNCT06416085
What this trial is testing

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

Who this might be right for
Advanced CancerStage IV Solid Tumor CancerStage IV Sarcoma of Bone+3 more
University Health Network, Toronto 15
Testing effectiveness (Phase 2)WithdrawnNCT01764009
What this trial is testing

Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Valerio Therapeutics
Testing effectiveness (Phase 2)Study completedNCT02076633
What this trial is testing

Intratumoral Administration of L19IL2/L19TNF

Who this might be right for
Malignant Melanoma, Skin
Philogen S.p.A. 21
Testing effectiveness (Phase 2)Study completedNCT02631447
What this trial is testing

Sequential Combo Immuno and Target Therapy (SECOMBIT) Study

Who this might be right for
Metastatic Melanoma
Fondazione Melanoma Onlus 251
Testing effectiveness (Phase 2)Ended earlyNCT00735332
What this trial is testing

Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma

Who this might be right for
Melanoma
Thallion Pharmaceuticals 49
Next Page